TrialBMC neurology2015

Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial.

Michael G Dwyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.